Anchorage AK 乳腺癌临床试验
7项针对 乳腺癌的研究正在 Anchorage及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
招募中3 期
- Alaska Oncology and Hematology LLC, Anchorage
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 以及另外 3 项
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
招募中3 期
- Alaska Oncology and Hematology, Anchorage
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
招募中3 期
- Anchorage Associates in Radiation Medicine, Anchorage
- Alaska Breast Care and Surgery LLC, Anchorage
- Alaska Oncology and Hematology LLC, Anchorage
- 以及另外 3 项
Effect of Meal Timing During Cancer Treatment in Patients in Alaska: A Randomized Clinical Trial
招募中
- Alaska Native Medical Center (ANMC), Anchorage
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
招募中观察性研究
- Katmai Oncology Group - Anchorage, Anchorage
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
招募中观察性研究
- Providence Alaska Medical Center, Anchorage
其他城市的 乳腺癌试验
- New York City, NY136 项研究
- Houston, TX126 项研究
- Boston, MA112 项研究
- Nashville, TN81 项研究
- Los Angeles, CA73 项研究
- Edison, NJ68 项研究
- St. Louis, MO64 项研究
- Queens, NY64 项研究
- Durham, NC64 项研究
- Chicago, IL59 项研究
- Philadelphia, PA56 项研究
- Dallas, TX55 项研究
Anchorage的其他研究
- 非小细胞肺癌8 项研究
- 卵巢癌7 项研究
- 肺癌6 项研究
- 前列腺癌4 项研究
- 胰腺癌4 项研究
- 子宫内膜癌4 项研究
- 胃癌3 项研究
- 食管癌3 项研究
- 癌症（所有类型）3 项研究
- 急性双表型白血病3 项研究
- 结直肠癌3 项研究
- 黑色素瘤3 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。